Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

bluebay shandong co.,ltd - methylene blue (unii: t42p99266k) (methylene blue - unii:t42p99266k) -

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - methylene blue(10mg/ml) - stain,antiseptic

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - methylene blue, quantity: 50 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australian pet supplies pty ltd - methylene blue; acriflavine; malachite green - misc. fish tank medication - methylene blue dye-blue active 4.0 mg/ml; acriflavine anilide/aniline active 2.0 mg/ml; malachite green dye-green active 0.4 mg/ml - parasiticides - fish aquarium freshwater | cold water | tropical - fin and tail rot | general fungal disease | velvet disease | white spot | fin rot | oodinium limneticum | oodinium pillularis | tail rot | whitespot

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

edenbridge pharmaceuticals llc. - ethacrynic acid (unii: m5dp350vzv) (ethacrynic acid - unii:m5dp350vzv) - ethacrynic acid tablets usp are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. - treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. - short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. - short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery di

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

cenexi hsc - methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - provayblue ® usp is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia. this indication is approved under accelerated approval. continued approval for this indication may be contingent upon verification of clinical benefit in subsequent trials [ see clinical studies ( 14.1) ]. provayblue ® is contraindicated in the following conditions: - severe hypersensitivity reactions to methylene blue or any other thiazine dye [see warnings and precautions ( 5.2)] . - patients with glucose-6-phosphate dehydrogenase deficiency (g6pd) due to the risk of hemolytic anemia [see warnings and precautions ( 5.3,

Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

parnell laboratories (aust) pty ltd (receivers/mngs app) - methylene blue - antidotes - animal - not applicable (vet)

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

kdg impresa llc, aqion - methylene blue (unii: t42p99266k) (methylene blue - unii:t42p99266k) -

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

zydus lifesciences limited - methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

australian nuclear science and technology organisation t/a ansto - medronic acid, quantity: 5 mg - injection, powder for - excipient ingredients: ascorbic acid; stannous chloride dihydrate; hydrochloric acid; sodium hydroxide - a bone imaging agent to delineate areas of altered osteogenesis.